Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|January 12, 2008
Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutantsIsabelle Marx, Peter J Lenting, Thure Adler, et al.
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
On the versatility of von Willebrand factorAntoine Rauch, Nikolett Wohner, Olivier D Christophe, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2015
Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearanceN Wohner, P Legendre, C Casari, et al.
FEBS Letters|April 6, 1992
Functional role of TTF-1 binding sites in bovine thyroglobulin promoterF Javaux, F Bertaux, A Donda, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Characterization of the interaction between von Willebrand factor and osteoprotegerinS Shahbazi, P J Lenting, C Fribourg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2009
Molecular characterization of Iranian patients with type 3 von Willebrand diseaseS Shahbazi, R Mahdian, F A Ala, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
von Willebrand factor clearance does not involve proteolysis by ADAMTS-13I Badirou, M Kurdi, J Rayes, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1990
Distinct transcriptional effects of cAMP on 2 thyroid specific genes: thyroperoxidase and thyroglobulinC M Gérard, A Lefort, D Christophe, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1989
Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanismsC M Gérard, A Lefort, D Christophe, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2016
LDL receptor-related protein 1 contributes to the clearance of the activated factor VII-antithrombin complexJ G Fazavana, V Muczynski, V Proulle, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Arteriosclerosis, Thrombosis, and Vascular Biology|January 12, 2008
Correction of bleeding symptoms in von Willebrand factor-deficient mice by liver-expressed von Willebrand factor mutantsIsabelle Marx, Peter J Lenting, Thure Adler, et al.
Mediterranean Journal of Hematology and Infectious Diseases|August 13, 2013
On the versatility of von Willebrand factorAntoine Rauch, Nikolett Wohner, Olivier D Christophe, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2015
Shear stress-independent binding of von Willebrand factor-type 2B mutants p.R1306Q & p.V1316M to LRP1 explains their increased clearanceN Wohner, P Legendre, C Casari, et al.
FEBS Letters|April 6, 1992
Functional role of TTF-1 binding sites in bovine thyroglobulin promoterF Javaux, F Bertaux, A Donda, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Characterization of the interaction between von Willebrand factor and osteoprotegerinS Shahbazi, P J Lenting, C Fribourg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2009
Molecular characterization of Iranian patients with type 3 von Willebrand diseaseS Shahbazi, R Mahdian, F A Ala, et al.
Journal of Thrombosis and Haemostasis : JTH|August 14, 2010
von Willebrand factor clearance does not involve proteolysis by ADAMTS-13I Badirou, M Kurdi, J Rayes, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1990
Distinct transcriptional effects of cAMP on 2 thyroid specific genes: thyroperoxidase and thyroglobulinC M Gérard, A Lefort, D Christophe, et al.
Molecular Endocrinology (Baltimore, Md.)|December 1, 1989
Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanismsC M Gérard, A Lefort, D Christophe, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2016
LDL receptor-related protein 1 contributes to the clearance of the activated factor VII-antithrombin complexJ G Fazavana, V Muczynski, V Proulle, et al.
Pageof 15